{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:28:12Z","timestamp":1790047692652,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.diagmicrobio.2019.114956","type":"journal-article","created":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T11:30:00Z","timestamp":1574767800000},"page":"114956","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The emergence of Staphylococcus epidermidis simultaneously nonsusceptible to linezolid and teicoplanin in China"],"prefix":"10.1016","volume":"96","author":[{"given":"Cailin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunguang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaogai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2019.114956_bb0005","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1128\/jb.178.15.4696-4703.1996","article-title":"Peptidoglycan synthesis and structure in Staphylococcus haemolyticus expressing increasing levels of resistance to glycopeptide antibiotics","volume":"178","author":"Billot-Klein","year":"1996","journal-title":"J Bacteriol"},{"issue":"9","key":"10.1016\/j.diagmicrobio.2019.114956_bb0010","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1128\/AAC.00380-13","article-title":"Clinical outcomes in patients with heterogeneous vancomycin-intermediate Staphylococcus aureus bloodstream infection","volume":"57","author":"Casapao","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2019.114956_bb0015","series-title":"Approved standard\u2014tenth edition M07-A10","article-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2015"},{"key":"10.1016\/j.diagmicrobio.2019.114956_bb0020","first-page":"M100","article-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2018","journal-title":"Twenty-Eighth Informational Supplement Informational Supplement"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2019.114956_bb0025","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1128\/JCM.02098-09","article-title":"Decreased susceptibility to teicoplanin and vancomycin in coagulase-negative Staphylococci isolated from orthopedic-device- associated infections","volume":"48","author":"Cremniter","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2019.114956_bb0030","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ijantimicag.2015.07.022","article-title":"Susceptibility trends including emergence of linezolid resistance among coagulase-negative staphylococci and meticillin-resistant Staphylococcus aureus from invasive infections","volume":"46","author":"Decousser","year":"2015","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2019.114956_bb0035","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1128\/AAC.02803-15","article-title":"Linezolid surveillance results for the United States (LEADER surveillance program 2014)","volume":"60","author":"Flamm","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2019.114956_bb0040","doi-asserted-by":"crossref","unstructured":"Folan SA, Marx KR, Tverdek FP, Raad I, Mulanovich VE, Tarrand JJ, et al. Clinical outcomes associated with linezolid resistance in leukemia patients withlinezolid-resistant Staphylococcus epidermidis bacteremia. Open Forum Infect Dis 2018;5(7):ofy167.","DOI":"10.1093\/ofid\/ofy167"},{"key":"10.1016\/j.diagmicrobio.2019.114956_bb0045","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0140-6736(86)90580-5","article-title":"Teicoplanin-resistant coagulase-negative staphylococcus","volume":"2","author":"Grant","year":"1986","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2019.114956_bb0050","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1099\/jmm.0.000490","article-title":"In vitro activities of vancomycin and linezolid against biofilm-producing methicillin-resistant staphylococci species isolated from catheter- related bloodstream infections from an Egyptian tertiary hospital","volume":"66","author":"Hashem","year":"2017","journal-title":"J Med Microbiol"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2019.114956_bb0055","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1128\/AAC.50.4.1156-1163.2006","article-title":"Distribution of florfenicol resistance genes fexA and cfr among chloramphenicol-resistant Staphylococcus isolates","volume":"50","author":"Kehrenberg","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2019.114956_bb0060","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3343\/alm.2016.36.3.235","article-title":"Clinical impact of heterogeneous vancomycin-intermediate Staphylococcus aureus isolated from hospitalized patients","volume":"36","author":"Koh","year":"2016","journal-title":"Ann Lab Med"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2019.114956_bb0065","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1089\/mdr.2015.0321","article-title":"Characterization of teicoplanin nonsusceptible Staphylococcus epidermidis clinical isolates belonging predominantly to ST267","volume":"23","author":"Liu","year":"2017","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.diagmicrobio.2019.114956_bb0070","series-title":"51(Suppl 2):ii9 \u2013ii16","article-title":"Linezolid in vitro: mechanism and antibacterial spectrum. J Antimicrob Chemother","author":"Livermore","year":"2003"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2019.114956_bb0075","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.1128\/AAC.01032-09","article-title":"Mutations in ribosomal protein L3 are associated with oxazolidinone resistance in staphylococci of clinical origin","volume":"53","author":"Locke","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2019.114956_bb0080","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.1128\/AAC.00644-10","article-title":"Mutations in 23S rRNA at the peptidyl transferase center and their relationship to linezolid binding and cross-resistance","volume":"54","author":"Long","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2019.114956_bb0085","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1017\/S0950268801005453","article-title":"Detection and typing of vancomycin-resistance genes of enterococci from clinical and nosocomial surveillance specimens by multiplex PCR","volume":"126","author":"Lu","year":"2001","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.diagmicrobio.2019.114956_bb0090","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1099\/jmm.0.034066-0","article-title":"Antibiotic susceptibility of coagulase-negative staphylococci (CoNS): emergence of teicoplanin-non-susceptible CoNS strains with inducible resistance to vancomycin","volume":"60","author":"Ma","year":"2011","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.diagmicrobio.2019.114956_bb0095","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1128\/AAC.00275-07","article-title":"Update to the multiplex PCR strategy for assignment of mec element types in Staphylococcus aureus","volume":"9","author":"Milheiri\u00e7o","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2019.114956_bb0100","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijantimicag.2005.11.013","article-title":"Heterogeneous resistance to vancomycin in Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus warneri clinical strains: characterisation of glycopeptide susceptibility profiles and cell wall thickening","volume":"4","author":"Nunes","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.diagmicrobio.2019.114956_bb0105","doi-asserted-by":"crossref","unstructured":"Pfaller MA, Mendes RE, Streit JM, Hogan PA, Flamm RK. Five-year summary of in vitro activity and resistance mechanisms of linezolid against clinically important gram-positive cocci in the United States from the LEADER Surveillance Program (2011 to 2015). Antimicrob Agents Chemother 2017; 61(7).","DOI":"10.1128\/AAC.00609-17"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2019.114956_bb0110","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/cid\/ciw113","article-title":"Causative organisms and associated antimicrobial resistance in healthcare-associated, central line-associated bloodstream infections from oncology settings, 2009\u20132012","volume":"62","author":"See","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2019.114956_bb0115","doi-asserted-by":"crossref","first-page":"7103","DOI":"10.1128\/JB.185.24.7103-7110.2003","article-title":"Alterations of cell wall structure and metabolaccompany reduced susceptibility to vancomycin in an isogenic series clinical isolates of Staphylococcus aureus","volume":"185","author":"Sieradzki","year":"2003","journal-title":"J Bacteriol"},{"key":"10.1016\/j.diagmicrobio.2019.114956_bb0120","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1128\/AAC.42.1.100","article-title":"Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci","volume":"1","author":"Sieradzki","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2019.114956_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jgar.2016.09.008","article-title":"cfr-mediated linezolid-resistant clinical isolates of methicillin-resistant coagulase-negative staphylococci from China","volume":"8","author":"Song","year":"2017","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.diagmicrobio.2019.114956_bb0130","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1128\/jcm.33.9.2233-2239.1995","article-title":"Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing","volume":"33","author":"Tenover","year":"1995","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2019.114956_bb0135","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1128\/JCM.01934-06","article-title":"Improved multilocus sequence typing scheme for Staphylococcus epidermidis","volume":"2","author":"Thomas","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2019.114956_bb0140","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1128\/JCM.44.5.1922-1923.2006","article-title":"High prevalence of teicoplanin resistance among Staphylococcus epidermidis strains in a 5-year retrospective study","volume":"44","author":"Trueba","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2019.114956_bb0145","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0140-6736(01)05410-1","article-title":"Linezolid resistance in a clinical isolate of Staphylococcus aureus","volume":"358","author":"Tsiodras","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.diagmicrobio.2019.114956_bb0150","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10096-011-1270-6","article-title":"Coagulase-negative staphylococci: update on the molecular epidemiology and clinical presentation, with a focus on Staphylococcus epidermidis and Staphylococcus saprophyticus","volume":"31","author":"Widerstrom","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2019.114956_bb0155","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1128\/AAC.49.8.3554-3557.2005","article-title":"Novel mechanism of resistance to oxazolidinones, macrolides, and chloramphenicol in ribosomal protein L4 of the pneumococcus. Antimicrob","volume":"49","author":"Wolter","year":"2005","journal-title":"Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2019.114956_bb0160","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/jac\/47.4.399","article-title":"A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital","volume":"4","author":"Wootton","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2019.114956_bb0165","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1348-0421.1997.tb01912.x","article-title":"Combined use of ribotyping, PFGE typing and IS431 typing in the discrimination of nosocomial strains of methicillin-resistant Staphylococcus aureus","volume":"41","author":"Yoshida","year":"1997","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.diagmicrobio.2019.114956_bb0170","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijid.2014.12.038","article-title":"Vancomycin intermediate-resistant Staphylococcus aureus (VISA) isolated from a patient who never received vancomycin treatment","volume":"33","author":"Zhu","year":"2015","journal-title":"Int J Infect Dis"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889319307746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889319307746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:53:11Z","timestamp":1760003591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889319307746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0732889319307746"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2019.114956","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The emergence of Staphylococcus epidermidis simultaneously nonsusceptible to linezolid and teicoplanin in China","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2019.114956","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114956"}}